ZTS
Zoetis Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-inputs (vergelijkbare managers):
breedte van houders +9.1% ·
aandelenstroom +1.4% ·
netto nieuwe posities +8.3%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 173 | +5 | 278.21M | $20.02B | +9 | −5 |
| Q1 2026 | 172 | -5 | 287.89M | $34.03B | +1 | −7 |
| Q4 2025 | 176 | -2 | 318.69M | $40.10B | +3 | −4 |
| Q3 2025 | 25 | -1 | 154.48M | $22.59B | n/a | −2 |
| Q2 2025 | 24 | +2 | 132.57M | $20.67B | +2 | n/a |
| Q1 2025 | 19 | 0 | 50.59M | $8.32B | n/a | n/a |
| Q4 2024 | 19 | +1 | 54.43M | $8.86B | +1 | n/a |
| Q3 2024 | 17 | 0 | 31.69M | $6.18B | +1 | −1 |
| Q2 2024 | 17 | n/a | 38.28M | $6.63B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 41.89M | n/a | $6.53B | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passief) | 37.24M | n/a | $5.81B | 0.1% | n/c | 1 | SEC ↗ ×22 |
| 3 | State Street Global Advisors ✦ (passief) | 19.74M | -0.3% | $3.08B | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 11.08M | +0.9% | $1.72B | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Wellington Management ✦ | 8.89M | +46.6% | $1.39B | 0.3% | ▲ Add | 5 | SEC ↗ ×5 |
| 6 | Norges Bank ✦ (passief) | 5.19M | +1.9% | $809.49M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 1.47M | +126.8% | $229.36M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 1.22M | +98.7% | $190.98M | 0.2% | ▲ Add | 5 | SEC ↗ ×7 |
| 9 | Millennium Management ✦ | 1.17M | +115.8% | $183.21M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 10 | Fidelity (FMR) ✦ | 1.09M | n/a | $169.75M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 11 | T. Rowe Price ✦ | 975.17K | -33.4% | $152.08M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 12 | D. E. Shaw & Co. ✦ | 767.64K | +131.7% | $119.71M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 710.82K | +754.5% | $110.85M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 14 | Capital World Investors ✦ | 695.39K | -82.5% | $108.45M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | Adage Capital Partners ✦ | 145.35K | -57.8% | $22.67M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 94.60K | Nieuw | $14.75M | 0.0% | New | 1 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 64.03K | -55.5% | $9.98M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 56.23K | +213.6% | $8.77M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 19 | Marshall Wace ✦ | 43.18K | -88.1% | $6.73M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | GAMCO Investors ✦ | 15.69K | +33.1% | $2.45M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 13.81K | -86.6% | $2.15M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Fisher Asset Management ✦ | 2.60K | -9.1% | $405,533 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 23 | Dodge & Cox ✦ | 1.50K | -11.8% | $233,925 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 24 | Harris Associates (Oakmark) ✦ | 1.41K | Nieuw | $219,110 | 0.0% | New | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Renaissance Technologies | $14.75M | 0.0% |
| Harris Associates (Oakmark) | $219,110 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,596 houders, 404.54M aandelen, $46.32B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.